A virtual cell built from protein data, not full genomic simulation, is now predicting how triple-negative breast cancer patients will respond to specific drugs. The Chinese-built AI model beat existing treatment-matching methods and flagged untested drug combinations that may work better.

— via 3 Quarks Daily, Azra Raza